In the study, nearly one-third of the people taking the drug developed an immune system reaction to the drug that rendered it ineffective. Humira (adalimumab) is often prescribed to people who have rheumatoid arthritis. Until now, doctors weren’t able to pinpoint why it relieves symptoms for some, while doing little for others.
“What the publication shows is that Humira may induce an immunological response against the drug,” said senior study author Dr. Gerrit Jan Wolbinks. “The immunological response works against the drug. This is one of the explanations why some patients do not respond the way we hope they will.”
The articles on this page are not necessarily the views of St.Vincent, and are not meant to be clinical advice. If you have questions regarding story content, please consult your physician.